STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 61 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,000 | -98.9% | 379 | -98.8% | 0.00% | – |
Q1 2021 | $90,000 | +13.9% | 32,600 | 0.0% | 0.00% | – |
Q4 2020 | $79,000 | +16.2% | 32,600 | 0.0% | 0.00% | – |
Q3 2020 | $68,000 | -44.7% | 32,600 | 0.0% | 0.00% | – |
Q2 2020 | $123,000 | +2360.0% | 32,600 | +1107.4% | 0.00% | – |
Q1 2020 | $5,000 | -93.5% | 2,700 | -92.7% | 0.00% | – |
Q4 2019 | $77,000 | -12.5% | 36,800 | 0.0% | 0.00% | – |
Q3 2019 | $88,000 | -23.5% | 36,800 | 0.0% | 0.00% | – |
Q2 2019 | $115,000 | -49.8% | 36,800 | +42.1% | 0.00% | – |
Q1 2018 | $229,000 | +175.9% | 25,900 | +125.2% | 0.00% | – |
Q4 2017 | $83,000 | +5.1% | 11,500 | 0.0% | 0.00% | – |
Q3 2017 | $79,000 | +29.5% | 11,500 | +35.3% | 0.00% | – |
Q2 2017 | $61,000 | – | 8,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,394,994 | $12,948,000 | 44.18% |
Vivo Capital, LLC | 3,000,000 | $7,200,000 | 2.37% |
Opaleye Management Inc. | 1,160,000 | $2,784,000 | 1.64% |
Granite Point Capital Management, L.P. | 606,607 | $1,456,000 | 1.16% |
Boxer Capital, LLC | 940,000 | $2,256,000 | 0.87% |
RA Capital Management | 2,279,099 | $5,470,000 | 0.78% |
Broadfin Capital, LLC | 2,894,581 | $6,947,000 | 0.77% |
NEA Management Company, LLC | 4,141,308 | $9,939,000 | 0.40% |
Tredje AP-fonden | 909,581 | $2,183,000 | 0.09% |
Anson Funds Management LP | 92,219 | $221,000 | 0.07% |